Fukuda Denshi Co (TSE:6960) ROCE %: 12.71% (As of Dec. 2025)


TSE:6960 Fukuda Denshi Co Ltd TSE:6960
79 GF Score
Price 円10,860.00
GF Value 円7,323.71
Valuation Significantly Overvalued
View Full Analysis

What is Fukuda Denshi Co ROCE %?

Fukuda Denshi Co TSE:6960 +1.78% 79 ROCE % is 12.71% as of Dec. 2025. GuruFocus rates TSE:6960 with a GF Score™ of 79/100 and a GF Value™ of 円7,323.71 (Significantly Overvalued).

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Fukuda Denshi Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 12.71%.


Fukuda Denshi Co  (TSE:6960) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Fukuda Denshi Co ROCE % Related Terms


Fukuda Denshi Co ROCE % Historical Data

* Premium members only.

The historical data trend for Fukuda Denshi Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fukuda Denshi Co ROCE % Chart

Fukuda Denshi Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.77 15.48 15.71 15.07 14.24

Fukuda Denshi Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.60 9.66 14.74 12.71 21.46
TSE:6960
79GF Score
Fukuda Denshi Co Ltd TSE:6960
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fukuda Denshi Co ROCE % Calculation

Fukuda Denshi Co's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=27084/( ( (221321 - 35219) + (225373 - 30967) )/ 2 )
=27084/( (186102+194406)/ 2 )
=27084/190254
=14.24 %

Fukuda Denshi Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=23464/( ( (212934 - 30098) + (215968 - 29662) )/ 2 )
=23464/( ( 182836 + 186306 )/ 2 )
=23464/184571
=12.71 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 12.71% mean?
Fukuda Denshi Co (TSE:6960) has a ROCE % of 12.71% as of Dec. 2025.
Is Fukuda Denshi Co's ROCE % too high?
Fukuda Denshi Co's current ROCE % is 12.71%. The Medical Devices & Instruments industry median ROCE % is 2.23. Fukuda Denshi Co's value of 12.71% is 470% above this industry median. Overall, Fukuda Denshi Co has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's ROCE % compare to ABT and SYK?
Fukuda Denshi Co's ROCE % of 12.71% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Fukuda Denshi Co's value of 12.71% is 470% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fukuda Denshi Co's current ROCE % of 12.71% is 470% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fukuda Denshi Co's current ROCE % is 12.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Based on GuruFocus' analysis, Fukuda Denshi Co (TSE:6960) is currently considered Significantly Overvalued. The stock's GF Value™ is 円7,323.71, compared to a current price of 円10,860.00 — trading 48.3% above its estimated fair value. The current ROCE % is 12.71% and 470% above the Medical Devices & Instruments industry median of 2.23. Fukuda Denshi Co's overall GF Score™ is 79/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Fukuda Denshi Co (TSE:6960), the current ROCE % is 12.71% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fukuda Denshi Co (TSE:6960) Overvalued in 2026?

Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued. The current stock price of 円10,860.00 is trading 48.3% above its estimated GF Value™ of 円7,323.71. GuruFocus considers Fukuda Denshi Co to be Significantly Overvalued.

Key valuation signals for TSE:6960:

  • ROCE %: 12.71%
  • GF Value™: 円7,323.71 vs. price of 円10,860.00 (48.3% above fair value)
  • GF Score™: 79/100
  • Industry Position: 470% above the Medical Devices & Instruments median

No single metric tells the full story. See the TSE:6960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fukuda Denshi Co Business Description

Address 39-4, Hongo 3-chome, Bunkyo-ku, Tokyo, JPN, 113-8483
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
79GF Score

Get the complete analysis for TSE:6960

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円10,860.00
Price
円7,323.71
GF Value